key: cord-0902301-75zhp1re
authors: Santos, Victor Santana; Gurgel, Ricardo Queiroz; Cuevas, Luis Eduardo; Martins-Filho, Paulo Ricardo
title: Prolonged fecal shedding of SARS-CoV-2 in pediatric patients. A quantitative evidence synthesis
date: 2020-05-15
journal: J Pediatr Gastroenterol Nutr
DOI: 10.1097/mpg.0000000000002798
sha: 2d524265802c40290a0eb19186265574144046bb
doc_id: 902301
cord_uid: 75zhp1re

OBJECTIVE: To investigate differences in viral shedding in respiratory and fecal samples from children with COVID-19. METHODS: We searched PubMed, SCOPUS, Embase and Web of Science databases to identify pediatric studies comparing the pattern of fecal and respiratory shedding of SARS-CoV-2 RNA. Summary estimates were calculated using random-effects models. RESULTS: Four studies reporting data from 36 children were included. A higher proportion of children had viral shedding in stools after 14 days of symptoms onset compared to respiratory samples (RR= 3.2, 95%CI 1.2 to 8.9, I2 = 51%). Viral RNA shedding was longer in fecal samples with a mean difference of approximately 9 days (Mean Difference = 8.6, 95%CI 1.7 to 15.4, I2 = 77%) compared with respiratory samples. CONCLUSION: SARS-CoV-2 shedding seems to be present in feces for a longer time than in the respiratory tract of children. Although fecal SARS-CoV-2 presence in feces do not confirm its transmissibility, the high and fast spread of the COVID-19 disease worldwide indicate other transmission routes are also plausible.

In late December 2019, the Novel Coronavirus Disease 19 emerged in Wuhan, Hubei Province, China, and rapidly spread to other countries around the world. Although COVID-19 is predominantly a respiratory disease mostly transmitted through respiratory droplets and skin to mucosae contact, other routes have been proposed, including fecal-oral Recently reports suggest that SARS-CoV-2 RNA remains detectable in the stools of children, even after tests of samples from their respiratory tracts have become negative, suggesting persistence of fecal viral shedding after symptom resolution. 6 We systematically investigated the differences in viral shedding patterns of respiratory and fecal samples from children with COVID-19.

This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. 7 Searches for studies were performed from January 1, 2020 up to April 19, 2020 in the peer-reviewed (PubMed, Embase, Web of Science, and Scopus) and grey literature, including Google Scholar and preprint publications in the bioRxiv and medRxiv repositories. The reference lists of all eligible studies were also scanned to identify additional studies for inclusion. The search terms used were:

"COVID-19", "SARS-CoV-2", "coronavirus", "pediatrics", "pediatric", "children", "neonates", "newborns", "shedding", and "viral load".

The following elements were used to define eligibility criteria: (1) population: children with COVID-19; (2) comparison groups: respiratory versus fecal samples; (3) outcomes: viral shedding of SARS-CoV-2 RNA detection by RT-PCT beyond 14 days of symptoms onset; (4) study type: observational studies.

Duration of viral shedding in respiratory swabs and stool samples was also extracted and defined as the number of days from symptoms onset to the day when the last specimen in which SARS-CoV-2 was detected. We excluded publications with potential overlapping reports based on data collection and setting and studies in which data extraction was not possible. In situations of studies with potential overlapping data, we selected the study with the most complete information.

Reports were screened in two stages: screening of titles and abstracts followed by the retrieval and screening of full-text articles. Two authors extracted data from all reports and crosschecked them for accuracy. The risk of bias assessment was conducted using the Joanna Briggs Critical Appraisal Tools for Case Series. 8 A random-effects meta-analysis was used to pool the individual measures from the included studies, and results were expressed as the risk ratio (RR) (for persistence of viral shedding) and the mean difference (MD) (for the duration of viral shedding) with 95% confidence intervals (CI). 

After screening 212 titles and abstracts, five full-text articles were assessed for eligibility. Of these, one case series of three patients was excluded. Four Although it is uncertain at this moment whether these are live virus or just RNA fragments, this finding could raise a concern on the isolation policy for the COVID-19 patients, particularly during the recovery phase. In summary, as SARS-CoV-2 RNA shedding seems to be present in feces for a longer time than in respiratory samples. Although fecal SARS-CoV-2 presence in feces does not confirm its transmissibility, the rapid and prolific spread of the COVID-19 disease worldwide indicates other transmission routes are also plausible. More evidence of SARS-CoV-2 RNA in stools is necessary to determine its longer term patterns of fecal excretion and whether asymptomatic and mildly ill individuals have persistence of fecal viral shedding.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission

Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

COVID-19 in children: the link in the transmission chain. Lancet Infect Dis

Characteristics of pediatric SARS

CoV-2 infection and potential evidence for persistent fecal viral shedding

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Systematic review of etiology and risk

novel coronavirus infection: clinical and epidemiological features

Do children need a longer time to shed SARS-CoV-2 in stool than adults?

Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha

Coronavirus Infections in Children Including COVID-19

Detection of SARS Coronavirus in Patients with Suspected SARS

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis

Digestive Symptoms in COVID

Patients With Mild Disease Severity

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China

Forest plot showing the risk of persistent viral shedding in fecal samples compared to respiratory tract swabs (A) and mean difference in duration of shedding between samples (B)